Researchers are now investigating whether a type of medication used to treat obesity could also help reduce asthma-related ...

Medically reviewed by Patricia Mikula, PharmD Key Takeaways GLP-1 drugs were linked to a significant reduction in asthma ...

In a recent cohort study published in JAMA Internal Medicine, researchers in England investigated the effects of metformin and other medications for type 2 diabetes (T2D) on asthma attacks. They found ...

Healthcare providers often prescribe GLP-1 drugs such as semaglutide (Ozempic and Wegovy) or liraglutide (Victoza and Saxenda) for type 2 diabetes control and weight loss. As these medications ...

Please provide your email address to receive an email when new articles are posted on . Adults who used a glucagon-like peptide receptor agonist for weight loss and had asthma experienced improved ...

MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds ...

Add Yahoo as a preferred source to see more of our stories on Google. Teens play basketball outside. Teens play basketball outside on a hot day in summer 2023 in New York City after the state issued ...

Early intervention with two asthma drugs may offer protection from pneumonia in patients infected with influenza, according to a new study published in PLOS Pathogens. Influenza pneumonia occurs when ...

Add Yahoo as a preferred source to see more of our stories on Google. Apr. 15—Patients in five states who have severe asthma and are covered by Blue Cross Blue Shield are facing a new obstacle to ...

From the studies conducted to date, tiotropium is a candidate to become a new therapeutic option in patients with asthma, in particular as step-up therapy in patients with severe persistent asthma who ...

NEW YORK (Reuters Health) - The use of beta-agonist inhalers, which include drugs such as Proventil (albuterol), for asthma appears to promote the accumulation of immune cells called type 2 T cells, ...

An asthma medication coverage policy by Health Care Services Corp. and its Illinois health plans that may lead to more at-home self-injections is meeting resistance from allergists, patients and an ...